Article
Rare APOA5 mutations--clinical consequences, metabolic and functional effects: an ENID review.
Atherosclerosis - 1 Oct 2007
Talmud Philippa J
Abstract excerpt
In 2001, a gene encoding a novel apolipoprotein (apo), APOA5, was identified by comparative human/mouse sequencing. The encoded protein, apoAV, had been missed in routine apolipoprotein identification because it occurs at very low plasma concentrations and only DNA analysis led to its identification. Knockout and transgenic mouse models of apoAV showed an inverse relationship with plasma triglyceride levels. In...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
